Breast Nodule Manager · BI-RADS Assessment & Follow-up — free guideline decision tool
Gives malignancy likelihood and follow-up/biopsy triage by ACR BI-RADS category.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| BI-RADS category (ultrasound/mammography) | 4A low suspicion |
|---|
→BI-RADSBI-RADS 4A low suspicion
- Malignancy likelihood (ACR BI-RADS Atlas, 5th ed., 2013)：>2–≤10%
- Triage：Tissue biopsy recommended.
- Scope：This tool covers BI-RADS assessment and follow-up triage only; surgery and systemic therapy after diagnosis are decided by the breast team per current guidelines.
| BI-RADS category (ultrasound/mammography) | 0 incomplete |
|---|
→BI-RADSBI-RADS 0 incomplete
- Malignancy likelihood (ACR BI-RADS Atlas, 5th ed., 2013)：—
- Triage：Needs additional imaging or comparison with prior studies before a final category.
- Scope：This tool covers BI-RADS assessment and follow-up triage only; surgery and systemic therapy after diagnosis are decided by the breast team per current guidelines.
Common questions
What is Breast Nodule Manager · BI-RADS Assessment & Follow-up?
Gives malignancy likelihood and follow-up/biopsy triage by ACR BI-RADS category.
How is Breast Nodule Manager · BI-RADS Assessment & Follow-up calculated? What is the core formula?
BI-RADS likelihood: 1–2 ≈0%; 3 ≤2%; 4A >2–≤10%; 4B >10–≤50%; 4C >50–<95%; 5 ≥95%; 6 pathology-proven. Enter each item; the result is calculated automatically and read with the clinical picture.
When is Breast Nodule Manager · BI-RADS Assessment & Follow-up used?
Follow-up and biopsy triage after an ultrasound or mammography BI-RADS category.
How should Breast Nodule Manager · BI-RADS Assessment & Follow-up results be interpreted?
1–2 routine screening, 3 short-interval follow-up, 4–5 tissue biopsy, 6 breast specialist referral. BI-RADS is an imaging likelihood, not a diagnosis; treatment after diagnosis is decided by the breast team.
What are the key clinical points for Breast Nodule Manager · BI-RADS Assessment & Follow-up?
BI-RADS 3: short-interval follow-up. BI-RADS 4–5: tissue biopsy. Biopsy pathology is the reference standard.
What are the limits and cautions when using Breast Nodule Manager · BI-RADS Assessment & Follow-up?
A benign result discordant with imaging needs re-evaluation. This page gives no surgical or systemic-therapy plan. For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
Does Breast Nodule Manager · BI-RADS Assessment & Follow-up upload patient data? Where is it calculated?
Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is Breast Nodule Manager · BI-RADS Assessment & Follow-up calculated in practice? Can you show a worked example?
Inputs: BI-RADS category (ultrasound/mammography) 4A low suspicion → Result: BI-RADS BI-RADS 4A low suspicion（Malignancy likelihood (ACR BI-RADS Atlas, 5th ed., 2013): >2–≤10%, Triage: Tissue biopsy recommended., Scope: This tool covers BI-RADS assessment and follow-up triage only; surgery and systemic therapy after diagnosis are decided by the breast team per current guidelines.） Inputs: BI-RADS category (ultrasound/mammography) 0 incomplete → Result: BI-RADS BI-RADS 0 incomplete（Malignancy likelihood (ACR BI-RADS Atlas, 5th ed., 2013): —, Triage: Needs additional imaging or comparison with prior studies before a final category., Scope: This tool covers BI-RADS assessment and follow-up triage only; surgery and systemic therapy after diagnosis are decided by the breast team per current guidelines.）
Run Breast Nodule Manager · BI-RADS Assessment & Follow-up now
Gives malignancy likelihood and follow-up/biopsy triage by ACR BI-RADS category.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.